» Authors » Matteo Turetta

Matteo Turetta

Explore the profile of Matteo Turetta including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 18
Citations 255
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Matrone F, Del Ben F, Montico M, Muraro E, Steffan A, Bortolus R, et al.
Prostate . 2024 Sep; 84(16):1468-1478. PMID: 39239745
Background: Stereotactic body radiation therapy (SBRT) is an effective metastasis-directed therapy for managing oligometastatic prostate cancer patients. However, it lacks reliable biomarkers for risk stratification. Circulating Tumor Cells (CTC) show...
2.
Del Ben F, Da Col G, Cobarzan D, Turetta M, Rubin D, Buttazzi P, et al.
Am J Clin Pathol . 2023 Sep; 160(6):620-632. PMID: 37658807
Objectives: This article addresses the need for effective screening methods to identify negative urine samples before urine culture, reducing the workload, cost, and release time of results in the microbiology...
3.
Boso D, Tognon M, Curtarello M, Minuzzo S, Piga I, Brillo V, et al.
J Exp Clin Cancer Res . 2023 Aug; 42(1):196. PMID: 37550722
Background: Genetic and metabolic heterogeneity are well-known features of cancer and tumors can be viewed as an evolving mix of subclonal populations, subjected to selection driven by microenvironmental pressures or...
4.
Brisotto G, Montico M, Turetta M, Zanussi S, Cozzi M, Vettori R, et al.
Viruses . 2023 Jun; 15(6). PMID: 37376576
Cellular and humoral immunity are both required for SARS-CoV-2 infection recovery and vaccine efficacy. The factors affecting mRNA vaccination-induced immune responses, in healthy and fragile subjects, are still under investigation....
5.
Muraro E, Del Ben F, Turetta M, Cesselli D, Bulfoni M, Zamarchi R, et al.
Front Oncol . 2022 Sep; 12:983887. PMID: 36081561
Background: Metastatic breast cancer (mBC) is a heterogeneous disease with varying responses to treatments and clinical outcomes, still requiring the identification of reliable predictive biomarkers. In this context, liquid biopsy...
6.
Turetta M, Del Ben F, Londero D, Steffan A, Pillinini P
Toxicol Rep . 2022 Apr; 9:636-639. PMID: 35399218
In this case report the hospital management of an acute, severe thrombocytopenia in a 57-year-old man in the north-east of Italy is reported. Thrombocytopenia developed immediately after the viper bite,...
7.
Da Col G, Del Ben F, Bulfoni M, Turetta M, Gerratana L, Bertozzi S, et al.
Front Oncol . 2022 Feb; 12:725318. PMID: 35223462
Background: The purpose of the present work was to test whether quantitative image analysis of circulating cells can provide useful clinical information targeting bone metastasis (BM) and overall survival (OS...
8.
Brisotto G, Muraro E, Montico M, Corso C, Evangelista C, Casarotto M, et al.
Clin Chim Acta . 2021 Nov; 523:476-482. PMID: 34755649
Background And Aims: Monitoring the immune response against SARS-CoV-2 is pivotal in the evaluation of long-term vaccine efficacy. Immunoglobulin G (IgG) antibodies represent an advisable tool to reach this goal,...
9.
Brisotto G, Biscontin E, Rossi E, Bulfoni M, Piruska A, Spazzapan S, et al.
Cancers (Basel) . 2020 Apr; 12(4). PMID: 32325824
Circulating tumor cells (CTCs) belong to a heterogeneous pool of rare cells, and a unequivocal phenotypic definition of CTC is lacking. Here, we present a definition of metabolically-altered CTC (MBA-CTCs)...
10.
Cesselli D, Ius T, Isola M, Del Ben F, Da Col G, Bulfoni M, et al.
Cancers (Basel) . 2019 Dec; 12(1). PMID: 31877896
(1) Background: Recently, it has been shown that the extent of resection (EOR) and molecular classification of low-grade gliomas (LGGs) are endowed with prognostic significance. However, a prognostic stratification of...